Tempest Therapeutics, Inc. Files 8-K for Special Meeting Proxy—Key Company and Voting Information Disclosed
Tempest Therapeutics, Inc. 8-K Filing Analysis Tempest T...
Sign in to continue:
Tempest Therapeutics, Inc. 8-K Filing Analysis Tempest T...
Chilean Cobalt Corp. Issues Update on Expiration of EXIM Let...
The Hanover Insurance Group: Q2 2026 Financial Results ...
Liberty Global Ltd. Authorizes Share Repurchase Program – Ke...
Galaxy Digital Inc. Announces Entry into Material Definitive...
Acadia Healthcare Company, Inc. - Q2 2026 Financial Report A...
Ranger Energy Services, Inc. Reports Strong Q2 2026 Results ...
FirstEnergy Corp. Q2 2026 Financial Results Detailed Investo...
Charlton Aria Acquisition Corporation Files 8-K: Key Executi...
Worksport Ltd. Reports Exceptional Gross Profit Growth in Q2...